SCHEMBL14728818

SCHEMBL14728818

FC(F)(F)Oc1ccc(/C=N/c2ccc(Br)cn2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
SLC7A5 Q01650 1/20 0.37
KCNH2 Q12809 2/20 0.36
SCN1A P35498 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN9A Q15858 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN8A Q9UQD0 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
ADRA2A P08913 2/20 0.36
ADRA2B P18089 2/20 0.36
ADRA2C P18825 2/20 0.36
PLAU P00749 1/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
BLM P54132 2/20 0.36
ALDH1A1 P00352 2/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14728822 0.81 APP (0.46) MEN1KMT2AMAPTALDH1A1PKM
SCHEMBL14728791 0.76 PKM (0.54) MEN1KMT2AADRA2AADRA2BADRA2C
SCHEMBL14728836 0.76 KMT2A (0.44) MEN1KMT2AADRA2AADRA2BADRA2C
SCHEMBL14728838 0.76 MAPT (0.54) MEN1KMT2AADRA2AADRA2BADRA2C
SCHEMBL14728827 0.72 KMT2A (0.41) MEN1KMT2AADRA2AADRA2BADRA2C
SCHEMBL3724578 0.70 SCN5A (0.44) KCNH2SCN1ASCN5ASCN9ASCN2A
SCHEMBL4470732 0.70 THRB (0.51) MEN1KMT2AKCNH2SCN1ASCN5A
SCHEMBL14728840 0.70 MAOB (0.43) MEN1KMT2AADRA2AADRA2BADRA2C
SCHEMBL21729900 0.69 MAPT (0.49) MEN1KMT2AKDM4EMAPTHTT
SCHEMBL220074 0.69 MAPT (0.47) MEN1KMT2AKCNH2SCN1ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026357-A1 PREPARATION METHOD OF IMIDAZOLE DERIVATIVES 北京欧博方医药科技有限公司 (CN) 2013-02-28 WO disclosed